Foresite Capital
Larkspur, Californiaforesitecapital.com
Overview
Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles. They use a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. The firm focuses on breakthrough opportunities at the intersection of tech and biotech, with a deeply technical investment team.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Remix Therapeutics | Jun 2026 | M&A | Co-investor |
| Quince Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Stepful | Jun 2026 | Series C | Co-investor |
| Avenzo Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
Key People
Cynthia Carpenter
Executive Associate to CEO and Founder, Jim Tananbaum
Jim Tananbaum
Founder And CEO
Cindy Xiong
Partner
Hyung Chun
Partner
Beata Lewandowska
Vice President Partner
Shoman Kasbekar
Principal
Matt Dyer 🇺🇦
Executive Advisor Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
